Anthracycline antibiotic blockade of SV40 T antigen helicase action (Q48031296)

7 February 2018

title

Anthracycline antibiotic blockade of SV40 T antigen helicase action (English)

1 reference

7 February 2018

author name string

Bachur NR

1

1 reference

7 February 2018

Lun L

2

1 reference

7 February 2018

Sun PM

3

1 reference

7 February 2018

Trubey CM

4

1 reference

7 February 2018

Elliott EE

5

1 reference

7 February 2018

Egorin MJ

6

1 reference

7 February 2018

Malkas L

7

1 reference

7 February 2018

Hickey R

8

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 April 1998

1 reference

7 February 2018

published in

Biochemical Pharmacology

1 reference

7 February 2018

volume

55

1 reference

7 February 2018

issue

7

1 reference

7 February 2018

page(s)

1025-1034

1 reference

7 February 2018

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

1 reference

The antitumor agent CC-1065 inhibits helicase-catalyzed unwinding of duplex DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

Structure-activity relationships of (+)-CC-1065 analogues in the inhibition of helicase-catalyzed unwinding of duplex DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

Correlation between anthracycline structure and human DNA ligase inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

Glutathione peroxidase and oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

Adriamycin-induced changes in the surface membrane of sarcoma 180 ascites cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

An immunoaffinity purification procedure for SV40 large T antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

DNA helicase activity of SV40 large tumor antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

7 January 2021

Mammalian DNA helicase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

The Combinations of Haemoglobin with Oxygen and with Carbon Monoxide. I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

Kinetics of pharmacologic response I. Proposed relationships between response and drug concentration in the intact animal and man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

A program package for simulation and parameter estimation in pharmacokinetic systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

Biological and physio-chemical properties of some N-acyl-daunorubicin derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

Molecular structural effects involved in the interaction of anthracyclines with DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

The interaction of daunorubicin and doxorubicin with DNA and chromatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

Biochemical and biological activity of the anthracycline analog, 4-demethyl-6-O-methyl-doxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

Interaction of new anthracycline antibiotics with DNA. Effects on nucleic acid synthesis and binding to DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

The interaction of nogalamycin and analogs with DNA and other biopolymers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

Menogaril, an anthracycline compound with a novel mechanism of action: cellular pharmacology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

Preferential binding of daunomycin to 5'ATCG and 5'ATGC sequences revealed by footprinting titration experiments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

Comparison of DNA sequence selectivity of anthracycline antibiotics and their 3'-hydroxylated analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

Enzymatic and chemical footprinting of anthracycline antitumor antibiotics and related saccharide side chains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

Strand-Specific Recognition of a Synthetic DNA Replication Fork by the SV40 Large Tumor Antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

Interaction of some daunomycin derivatives with deoxyribonucleic acid and their biological activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

Circumvention of resistance by doxorubicin, but not by idarubicin, in a human leukemia cell line containing an intercalator-resistant form of topoisomerase II: evidence for a non-topoisomerase II-mediated mechanism of doxorubicin cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

Mutagenicity of anticancer drugs that inhibit topoisomerase enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900617-5

10.1016/S0006-2952(97)00617-5

7 January 2021

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018